SEC 13F Intelligence

Managers / Q3 2020 · view latest →

HARBOURVEST PARTNERS LLC

CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707

Reported Value
$270M
Q3 2020
Positions
36
Filings on Record
32
2019–present window
Filed
Nov 12, 2020
original filing

Summary

Harbourvest Partners LLC reported $270M in U.S.-listed holdings across 36 positions for Q3 2020.

The portfolio is heavily concentrated: SWIUSD alone accounts for 59.3% of reported value.

Compared with Q2 2020, the fund opened 12 new positions and exited 5.

Portfolio Metrics

Turnover
+12.5%
vs prior filed quarter
Top-10 Concentration
+90.4%
share of reported value
Largest Position
+59.3%
Solarwinds
New / Exited
12 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $211MQ4 ’18Q1 ’19: $283MQ2 ’19: $262MQ3 ’19: $240MQ4 ’19: $243MQ4 ’19Q1 ’20: $207MQ2 ’20: $232MQ3 ’20: $270MQ4 ’20: $256MQ4 ’20Q1 ’21: $746MQ2 ’21: $1.0BQ3 ’21: $1.1BQ4 ’21: $782MQ4 ’21Q1 ’22: $490MQ2 ’22: $305MQ3 ’22: $306MQ4 ’22: $299MQ4 ’22Q1 ’23: $297MQ2 ’23: $352MQ3 ’23: $295MQ4 ’23: $299MQ4 ’23Q1 ’24: $219MQ2 ’24: $188MQ3 ’24: $192MQ4 ’24: $203MQ4 ’24Q1 ’25: $154MQ2 ’25: $91MQ3 ’25: $205MQ4 ’25: $174MQ4 ’25Q1 ’26: $101Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 82.6%Other: 16.5%ADR: 0.9%
  • Common Stock · 82.6% · $223M
  • Other · 16.5% · $45M
  • ADR · 0.9% · $2M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TDOCTelaDoc Health, Inc.NEW+50.9K50.9K+$11M$11M
1Life Healthcare, Inc.NEW+351.5K351.5K+$10M$10M
PGNYProgyny, Inc.NEW+87.6K87.6K+$3M$3M
NTNXNutanix, Inc.NEW+106.0K106.0K+$2M$2M
PDPagerDuty, Inc.NEW+67.9K67.9K+$2M$2M
Crispr Therapeutics AGNEW+21.4K21.4K+$2M$2M
CNSTConstellation Pharmaceuticals, Inc.NEW+49.6K49.6K+$1M$1M
PHRPhreesia, Inc.NEW+24.6K24.6K+$789,000$789,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2020

36 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1SWIUSDSolarwinds Corp.history →Common59.26%$160M7.87M
2KLDOKaleido BioSciences, Inc.history →Common7.51%$20M1.83M
3Evelo Biosciences, Inc.Common5.97%$16M3.06M
4Axcella Health, Inc.Common4.80%$13M2.81M
5TDOCTelaDoc Health, Inc.history →Common4.13%$11M50.9K
61Life Healthcare, Inc.Common3.69%$10M351.5K
7RUBYUSDRubius Therapeutics, Inc.history →Common1.83%$5M986.9K
8KLDOCornerstone OnDemand Inc.history →Common1.16%$3M86.2K
9PluralSight, Inc.Common CL A1.12%$3M176.8K
10PGNYProgyny, Inc.Common0.95%$3M87.6K
11OPHTEURIVERIC Bio, Inc.Common0.92%$2M442.8K
12LOVUSDSpark Networks SESponsored ADR0.91%$2M502.6K
13LCEURLendingClub Corp.Common0.89%$2M513.4K
14NTNXNutanix, Inc.Common CL A0.87%$2M106.0K
15PDPagerDuty, Inc.Common0.68%$2M67.9K
16SFIXStitchfix, Inc.Common CL A0.67%$2M66.6K
17Crispr Therapeutics AGNamen AKT0.66%$2M21.4K
18YEXTYext, Inc.Common0.65%$2M115.1K
19ZUOUSDZuora, Inc.Common0.63%$2M163.9K
20CNSTConstellation Pharmaceuticals, Inc.Common0.37%$1M49.6K
21PHRPhreesia, Inc.Common0.29%$789,00024.6K
22VCYTVeracyte, Inc.Common0.28%$766,00023.6K
23LYFTLyft, Inc.Common CL A0.26%$710,00025.8K
24Trevena, Inc.Common0.26%$699,000233.8K
25CTMXCytomx Therapeutics, Inc.Common0.20%$527,00079.2K
26PTIEURProteostasis Therapeutics, Inc.Common0.18%$485,000440.6K
27CSLT1EURCastlight Health, Inc.Common CLB0.15%$394,000349.1K
28ARVNArvinas, Inc.Common0.15%$393,00016.7K
29ARAntero Resources LLCCommon0.13%$363,000131.9K
30EPZMEUREpizyme, Inc.Common0.11%$295,00024.7K
31BDTXBlack Diamond Therapeutics, Inc.Common0.11%$290,0009.6K
32XGNExagen, Inc.Common0.10%$282,00026.0K
33REALThe RealReal, Inc.Common0.04%$106,0007.3K
34NXTCEURNextCure, Inc.Common0.03%$88,00010.0K
35Ramaco Resources, Inc.Common0.02%$52,00015.0K
36HNRGHallador Energy Resources, Inc.Common0.00%$9,00014.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$101M5May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$174M7Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$205M9Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$91M15Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$154M16May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$203M22Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$192M34Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$188M40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$219M48May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$299M53Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$295M58Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$352M60Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$297M63May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$299M65Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$306M67Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$305M62Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$490M66May 26, 2022RESTATEMENTchanges · EDGAR ↗
Q4 2021$782M67Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.1B56Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.0B51Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$746M44May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$256M26Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$270M36Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$232M28Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$207M36May 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$243M35Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$240M33Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$262M32Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$283M33May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$211M32Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.